PrintThe Burrill Report
The Burrill Report (January 6, 2014): A Look at 2013, the J.P. Morgan Conference, and Beyond (.MP3,18.86 Mb)
Biotech stocks soared in 2013 and, as the industry readies for the annual J.P. Morgan Healthcare Conference in San Francisco January 13-16, there’s little to temper investor enthusiasm for the sector. We spoke to Adam Feuerstein, senior columnist for TheStreet.com, about the year that was in biotech, what to be watching at JPMorgan conference, and what the new year will bring for the sector.
January 02, 2014
http://www.burrillreport.com/article-a_look_at_2013_the_j_p_morgan_conference_and_beyond.html
CAPITAL MARKETS
A Look at 2013, the J.P. Morgan Conference, and Beyond
Podcast: January 6, 2014[Please login to post comments]
- Global Life Sciences M&A; Deal Values Hit $131.8B in 2013
Big Pharma takes a breather from M&A.; Read More - Asia’s Share of Biomedical R&D; Investment Grows
With lure of lower cost labor and subsidies, industry appears to be shifting investments East. Read More - Drugmakers Launch Data-sharing Site
New patient-level data will open avenues for further research of approved medicines. Read More - FDA Rebuffs Genzyme’s Lemtrada for Relapsing MS
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - Banner Year for Life Sciences IPOs
More than three quarters of the 52 companies that went public ended the year above their initial offering price. Read More - Buyout Firm Acquires Majority Stake in Ikaria
Critical therapy company will pursue international expansion while spinning out part of pipeline. Read More - Tesaro Reports Positive Results, but Not Good Enough as Investors Sink Shares
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More - Fighting Cancer with Gene Therapy
Podcast: December 30, 2013 Read More - Alzheimer’s Disease Unraveled
Researchers clarify where it starts, why it starts there, and how it spreads. Read More - Merck Launches New Weight Management Business
Partnership with Health Management Resources seeks to lower healthcare costs, minimize chronic disease risks. Read More
.gif)
